Found: 23
Select item for more details and to access through your institution.
Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc.
- Published in:
- Prostate, 1998, v. 34, n. 3, p. 175, doi. 10.1002/(SICI)1097-0045(19980215)34:3<175::AID-PROS4>3.0.CO;2-H
- By:
- Publication type:
- Article
Induction of differentiation and c-jun expression in human leukemic cells by okadaic acid, an inhibitor of protein phosphatases.
- Published in:
- Journal of Cellular Physiology, 1992, v. 151, n. 2, p. 415, doi. 10.1002/jcp.1041510223
- By:
- Publication type:
- Article
Differentiation of HL-60 cells is associated with an increase in the 35-kDa protein lipocortin I.
- Published in:
- Journal of Cellular Physiology, 1988, v. 137, n. 3, p. 402, doi. 10.1002/jcp.1041370303
- By:
- Publication type:
- Article
Bryostatin 1: will the oceans provide a cancer cure?
- Published in:
- 1993
- By:
- Publication type:
- commentary
Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation.
- Published in:
- European Journal of Immunology, 2012, v. 42, n. 4, p. 1044, doi. 10.1002/eji.201040746
- By:
- Publication type:
- Article
Pim1 Serine/Threonine Kinase Regulates the Number and Functions of Murine Hematopoietic Stem Cells.
- Published in:
- Stem Cells, 2013, v. 31, n. 6, p. 1202, doi. 10.1002/stem.1369
- By:
- Publication type:
- Article
EDC3 phosphorylation regulates growth and invasion through controlling P‐body formation and dynamics.
- Published in:
- EMBO Reports, 2021, v. 22, n. 4, p. 1, doi. 10.15252/embr.202050835
- By:
- Publication type:
- Article
The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells.
- Published in:
- Oncogene, 2003, v. 22, n. 32, p. 4953, doi. 10.1038/sj.onc.1206656
- By:
- Publication type:
- Article
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells.
- Published in:
- Oncogene, 2002, v. 21, n. 7, p. 1135, doi. 10.1038/sj.onc.1205151
- By:
- Publication type:
- Article
PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 5, p. 974, doi. 10.1002/1878-0261.12662
- By:
- Publication type:
- Article
Regulation of myeloid cell growth by distinct effectors of Ras.
- Published in:
- Oncogene, 1998, v. 17, n. 21, p. 2701, doi. 10.1038/sj.onc.1202201
- By:
- Publication type:
- Article
A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomasPresented, in part, at the 39th Annual Meeting of the American Society of Clinical Oncology, Chicago, Illinois, May 31June 3, 2003 (abstract 3291).
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 7, p. 1431
- By:
- Publication type:
- Article
PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An XBP1s–PIM-2 positive feedback loop controls IL-15–mediated survival of natural killer cells.
- Published in:
- Science Immunology, 2023, v. 8, n. 81, p. 1, doi. 10.1126/sciimmunol.abn7993
- By:
- Publication type:
- Article
Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells.
- Published in:
- Cell Death & Differentiation, 1999, v. 6, n. 2, p. 175, doi. 10.1038/sj.cdd.4400477
- By:
- Publication type:
- Article
Regulation of AP-3 enhancer activity during hematopoietic differentiation.
- Published in:
- Journal of Cellular Physiology, 1995, v. 164, n. 1, p. 26, doi. 10.1002/jcp.1041640105
- By:
- Publication type:
- Article
Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-12
- By:
- Publication type:
- Article
The 2014 Surgeon General's report: 'The Health Consequences of Smoking-50 Years of Progress': A paradigm shift in cancer care.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A randomized, open‐label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft‐tissue sarcoma.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 894, doi. 10.1002/cncr.33216
- By:
- Publication type:
- Article
Targeted glycoprotein enrichment and identification in stromal cell secretomes using azido sugar metabolic labeling.
- Published in:
- Proteomics - Clinical Applications, 2013, v. 7, n. 5/6, p. 367, doi. 10.1002/prca.201300006
- By:
- Publication type:
- Article
Phase I dose escalation study of vinorelbine and topotecancombination chemotherapy in patients with recurrent lung cancer.
- Published in:
- BMC Cancer, 2007, v. 7, p. 231, doi. 10.1186/1471-2407-7-231
- By:
- Publication type:
- Article